Product Information

ATORVASTATIN 20 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0284 per EA under NDC 31722042590. Its NADAC has been published 133 times since May 8, 2024.

FDA first approved this application on Sep 12, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ATORVASTATIN 20 MG TABLET

ATORVASTATIN CALCIUM
$0.0284per EA

Strength

20 mg/1

NDC

31722042590

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214344

FDA Approved

9/12/2023

TE Code

AB

On Market Since

9/12/2023

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 20 MG TABLET has been published 133 times since May 8, 2024, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0284 per EA
All-time high$0.0398 (Sep 11, 2024)
All-time low$0.0276 (Aug 19, 2026)
52-week high$0.0310
52-week low$0.0276
Median price$0.0317
Average price$0.0320
Largest weekly change+32.4% (Aug 21, 2024)
Weeks tracked133
Tracking sinceMay 8, 2024

Price History

1W

-0.6%

1M

+1.8%

3M

+2.9%

6M

-2.1%

1Y

-8.2%

3Y

N/A

5Y

N/A

All

-16.3%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0284 per EA (NDC 31722042590), effective Nov 18, 2026.

How has the price of ATORVASTATIN 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 16.3%. It has been tracked across 133 weekly CMS publications since May 8, 2024.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?

Since May 8, 2024, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0276 (Aug 19, 2026) to a high of $0.0398 (Sep 11, 2024), with a median of $0.0317 per EA.

Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ATORVASTATIN 20 MG TABLET?

ATORVASTATIN 20 MG TABLET (NDC 31722042590) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.